[ Price : $8.95]
FDA approves a Watson and Antares Pharma NDA for a topical oxybutynin gel 3% product to treat overactive bladder.[ Price : $8.95]
FDAs Oncologic Drugs Advisory Panel recommends Pfizers axitinib for treating some advanced renal cell carcinoma patients.[ Price : $8.95]
JDRF praises FDA for responding to its concerns about a draft artificial pancreas study guidance.[ Price : $8.95]
Federal Register Notice: FDA plans a public meeting 12/19 to discuss the proposed recommendations for enacting a Generic Drug User...[ Price : $8.95]
Trade association LifeScience Alley and CDRH sign a memorandum of understanding to advance regulatory science.[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee says that Affymax and Takedas peginesatide is effective in treating dialysis patients with...[ Price : $8.95]
Researchers writing in Health Affairs discuss clinical trial registration, off-label marketing, and controls on use of atypical an...[ Price : $8.95]
FDAs Circulatory Systems Devices Panel votes that Medtronics cardiac resynchronization therapy with implantable cardioverter defib...